Brain Protein Expression Profile Confirms the Protective Effect of the ACTH(4–7)PGP Peptide (Semax) in a Rat Model of Cerebral Ischemia–Reperfusion
Open accessThe DOI matches its Crossref record; 61 of the 64 references it cites were found in a registry or an index; 14 of the 39 sources its claims cite were checked for support.
Abstract
The Semax (Met-Glu-His-Phe-Pro-Gly-Pro) peptide is a synthetic melanocortin derivative that is used in the treatment of ischemic stroke. Previously, studies of the molecular mechanisms underlying the actions of Semax using models of cerebral ischemia in rats showed that the peptide enhanced the transcription of neurotrophins and their receptors and modulated the expression of genes involved in the immune response. A genome-wide RNA-Seq analysis revealed that, in the rat transient middle cerebral artery occlusion (tMCAO) model, Semax suppressed the expression of inflammatory genes and activated the expression of neurotransmitter genes. Here, we aimed to evaluate the effect of Semax in this model via the brain expression profiling of key proteins involved in inflammation and cell death processes (MMP-9, c-Fos, and JNK), as well as neuroprotection and recovery (CREB) in stroke. At 24 h after tMCAO, we observed the upregulation of active CREB in subcortical structures, including the focus of the ischemic damage; downregulation of MMP-9 and c-Fos in the adjacent frontoparietal cortex; and downregulation of active JNK in both tissues under the action of Semax. Moreover, a regulatory network was constructed. In conclusion, the suppression of inflammatory and cell death processes and the activation of recovery may contribute to the neuroprotective action of Semax at both the transcriptome and protein levels.
Overview
CoChat Summary
## TL;DR
In a rat transient middle cerebral artery occlusion (tMCAO) model, Semax altered protein and gene-expression markers in ways the authors interpret as neuroprotective at 24 h after ischemia–reperfusion. The main reported effects were decreased pJNK in both subcortex and cortex, increased pCREB in subcortex, and reduced MMP-9 and c-Fos in the adjacent frontoparietal cortex.
## Key findings
- At 24 h after tMCAO, ischemia–reperfusion increased pJNK by more than two-fold in both subcortex and cortex; Semax reduced pJNK by more than 1.5-fold.
- In the subcortex, ischemia reduced pCREB by more than 1.4-fold, and Semax increased pCREB by more than 1.5-fold; pCREB in cortex was unchanged by ischemia, and Semax caused a non-significant increase.
- In the cortex, IR increased MMP-9 and c-Fos protein levels by about two-fold; Semax decreased both by more than 1.5-fold. In the adjacent frontoparietal cortex, Semax also lowered Mmp9 mRNA by approximately 1.7-fold and Fos mRNA by 2.6-fold.
- The authors report that Semax did not significantly change MMP-9 or c-Fos in the subcortex, despite ischemia-related increases in MMP-9 there by approximately 1.7-fold.
## Methods
- Adult male Wistar rats (2-month-old, 200–250 g) underwent 90 min right middle cerebral artery occlusion under MRI control, followed by reperfusion; animals were sacrificed 24 h later.
- Groups included Semax-treated ischemia (100 μg/kg intraperitoneally immediately after occlusion and again at 1.5 and 5 h after reperfusion), saline-treated ischemia/reperfusion, and sham-operated controls; at least six animals were included per comparison for RT–PCR and 5–7 per group for protein analysis.
- The study used histology (H&E), Western blotting for pJNK, pCREB, MMP-9, c-Fos, and real-time RT–PCR for Mmp9 and Fos mRNA; statistics used Student’s t test and p < 0.05.
## Limitations
- The paper explicitly states that it analyzed the expression of only four proteins, and that genome-wide proteomic analysis might reveal additional proteins involved in the response to Semax.
- The text also makes evident that the study focused on a single time point (24 h after occlusion) and a rodent model, so the findings do not by themselves establish longer-term effects or human efficacy (evident from the study design, not stated as a limitation).
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures



![Figure 4 Scheme of JNK and CREB participation in the signaling pathways identified by us previously [17,22] and associated with ischemia–reperfusion and Semax action in the subcortical structures of the brain at 24 h after tMCAO. The network was constructed using the Cytoscape 3.7.0 program. The oval blocks at the nodes represent proteins. The gray rectangular boxes represent signaling pathways. The lines connecting the oval and rectangular blocks indicate the participation of the protein in the signaling pathway.](https://figures.cochat.ai/paper-figures/d123e042dd914c188ac191034817d17c/brain-protein-expression-profile-confirms-the-protective-effect-of-the-acth-47-figure-4.jpg)
Verification
Claims the paper makes
11 Valid · 0 Not valid · 15 Not checked · 48 Own results and interpretations
The sources with a verdict support this claim; the rest weren’t checked yet, have no full text we could read, or their verdicts aren’t rated yet.
In the paper
“significantly affects the expression of genes associated with the processes of the immune response [15,16]”
§ Brain Protein Expression Profile Confirms the Protective Effect of the ACTH(4–7)PGP Peptide (Semax) in a Rat Model of Cerebral Ischemia–Reperfusion > 1. Introduction
What the sources say
- Supportedcites [15] Medvedeva E.V. Dmitrieva V.G. Povarova O.V. Limborska S.A. Skvortsova V.I. Myasoedov N.F. Dergunova L.V. The peptide semax affects the expression of genes related to the immune and vascular systems in rat brain focal ischemia: Genome-wide transcriptional analysis BMC Genom. 2014 15 228 10.1186/1471-2164-15-228 PMC3987924 24661604 source
The Conclusions state that Semax most markedly affected the immune response in rat brain cortical cells under experimental focal ischemia, enhancing chemokine and immunoglobulin gene expression. The Results also report altered gene expression in ischemia-damaged rat brain cortex after Semax administration. Page numbers were not provided in our copy. (LLM, conf=0.92)
- Not checked — no full text of the sourcecites [16] Medvedeva E.V. Dmitrieva V.G. Limborska S.A. Myasoedov N.F. Dergunova L.V. Semax, an analog of ACTH(4-7), regulates expression of immune response genes during ischemic brain injury in rats Mol. Genet. Genom. 2017 292 635 653 10.1007/s00438-017-1297-1 28255762 source
boostedstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The sources with a verdict support this claim; the rest weren’t checked yet, have no full text we could read, or their verdicts aren’t rated yet.
In the paper
“it enhances the transcription of neurotrophins and their receptors [13,14]”
§ Brain Protein Expression Profile Confirms the Protective Effect of the ACTH(4–7)PGP Peptide (Semax) in a Rat Model of Cerebral Ischemia–Reperfusion > 1. Introduction
What the sources say
- Supportedcites [13] Dmitrieva V.G. Povarova O.V. Skvortsova V.I. Limborska S.A. Myasoedov N.F. Dergunova L.V. Semax and Pro-Gly-Pro activate the transcription of neurotrophins and their receptor genes after cerebral ischemia Cell. Mol. Neurobiol. 2010 30 71 79 10.1007/s10571-009-9432-0 19633950 PMC11498467 source
The Discussion reports that Semax upregulated transcription of neurotrophins and their receptors in the ischemic cortex of rats after occlusion. It identifies increases in Bdnf, TrkA, and TrkC mRNA at 3 hours and Nt-3 and Ngf mRNA at 24 hours, supporting the attributed claim. (LLM, conf=0.94)
- Not checked — no full text of the sourcecites [14] Stavchansky V.V. Yuzhakov V.V. Botsina A.Y. Skvortsova V.I. Bondurko L.N. Tsyganova M.G. Limborska S.A. Myasoedov N.F. Dergunova L.V. The effect of Semax and its C-end peptide PGP on the morphology and proliferative activity of rat brain cells during experimental ischemia: A pilot study J. Mol. Neurosci. 2011 45 177 185 10.1007/s12031-010-9421-2 20617398 source
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“It should be noted that CREB activation and JNK inhibition are involved in the anti-inflammatory and neuroprotective action of melanocortins in models of ischemic and inflammatory processes in the brain [4,60].”
§ Brain Protein Expression Profile Confirms the Protective Effect of the ACTH(4–7)PGP Peptide (Semax) in a Rat Model of Cerebral Ischemia–Reperfusion > 5. Conclusions
What the sources say
- Partly supportedcites [4] Mykicki N. Herrmann A.M. Schwab N. Deenen R. Sparwasser T. Limmer A. Wachsmuth L. Klotz L. Köhrer K. Faber C. Melanocortin-1 receptor activation is neuroprotective in mouse models of neuroinflammatory disease Sci. Transl. Med. 2016 8 362 10.1126/scitranslmed.aaf8732 27797962 sourceExperimental — accuracy not yet measured
The Results section ('NDP-MSH induces neuroprotection and restores action potential generation by upregulating the orphan nuclear receptor Nr4a1') and the Discussion support the CREB half of the claim: Mc1r ligation by NDP-MSH increased phospho-CREB, driving CREB-dependent Nr4a1 activation and protection of murine and human neurons under excitotoxic/inflammatory conditions. However, our copy contains nothing on JNK inhibition — the pathway partners the paper actually tested and reports are phospho-CREB and phospho-p38 MAPK, and it states NDP-MSH 'did not modulate the levels of phospho-p38 MAPK'; JNK appears only in the title of a cited reference (Zhou et al., ref. 36). Likewise, no ischemic model is used anywhere in our copy: the models are EAE/opticospinal encephalomyelitis, Devic's disease tissue, and glutamate-induced excitotoxicity, so the 'models of ischemic … processes in the brain' extension is not attributable to this source. (LLM, conf=0.82)
- Partly supportedcites [60] Chen S. Zhao L. Sherchan P. Ding Y. Yu J. Nowrangi D. Tang J. Xia Y. Zhang J.H. Activation of melanocortin receptor 4 with RO27-3225 attenuates neuroinflammation through AMPK/JNK/p38 MAPK pathway after intracerebral hemorrhage in mice J. Neuroinflammation 2018 15 10.1186/s12974-018-1140-6 29642894 PMC5896146 sourceExperimental — accuracy not yet measured
The Discussion (page unavailable) reports that RO27-3225 reduced phosphorylated JNK and inflammatory cytokines and improved neurobehavioral outcomes after intracerebral hemorrhage in mice. The Background also discusses protective effects in cerebral ischemia, but the paper does not identify CREB activation as a mechanism; its proposed pathway involves AMPK, JNK, and p38 MAPK. (LLM, conf=0.88)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“We have previously shown that, in the subcortical structures of the brain containing the focus of ischemic damage, Semax initiates a large-scale neurotransmitter and anti-inflammatory response that counteracts ischemia–reperfusion [17].”
§ Brain Protein Expression Profile Confirms the Protective Effect of the ACTH(4–7)PGP Peptide (Semax) in a Rat Model of Cerebral Ischemia–Reperfusion > 3. Discussion
What the sources say
- Supportedcites [17] Filippenkov I.B. Stavchansky V.V. Denisova A.E. Yuzhakov V.V. Sevan’kaeva L.E. Sudarkina O.Y. Dmitrieva V.G. Gubsky L.V. Myasoedov N.F. Limborska S.A. Novel insights into the protective properties of acth(4-7)pgp (semax) peptide at the transcriptome level following cerebral ischaemia– reperfusion in rats Genes 2020 11 681 10.3390/genes11060681 PMC7350263 32580520 source
The Conclusions report that, in subcortical brain tissue under transient ischemia–reperfusion conditions, Semax suppressed inflammatory genes and activated neurotransmitter genes, counteracting the expression changes caused by ischemia–reperfusion. The Discussion describes this as an effect on several hundred genes; the response measured was at the transcriptome level. (LLM, conf=0.91)
boostedstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“At 24 h after tMCAO, we observed the upregulation of active CREB in subcortical structures, including the focus of the ischemic damage”
- Also stated in: § 2.2. Changes in the Levels of pJNK, pCREB, MMP-9, and c-Fos in the Subcortical Structures and Cortex of the Rat Brain under the Conditions of Ischemia–Reperfusion · plain
“whereas Semax increased its levels by more than 1.5-fold (Figure 2c).”
- Also stated in: § 3. Discussion · plain
“In our experiment, a decrease in the level of pCREB was detected under the conditions of ischemia–reperfusion in the subcortical structures of the brain at 24 h after the onset of occlusion, which was completely rescued by Semax.”
§ Brain Protein Expression Profile Confirms the Protective Effect of the ACTH(4–7)PGP Peptide (Semax) in a Rat Model of Cerebral Ischemia–Reperfusion > Abstract
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Also stated in: § 2.2. Changes in the Levels of pJNK, pCREB, MMP-9, and c-Fos in the Subcortical Structures and Cortex of the Rat Brain under the Conditions of Ischemia–Reperfusion · plain
36 more claims
Create a free account to see all 74 claims and to verify the 6 references still open.
- It may state two separate claims as one. 21
- Probably not a substantial claim. 16
Citations
Cites
Cytoscape: A software Environment for integrated models of biomolecular interaction networks
Shannon, P., Markiel, A., Ozier, O., Baliga, N. S., Wang, J. T., Ramage, D., Amin, N., Schwikowski, B., & Ideker, T. (2003) · Genome Research · doi:10.1101/gr.1239303 · Cited by 51,888 · cited 2×
“The use of the Cytoscape 3.7.0 program (Institute for Systems Biology, Seattle, WA, USA) [23] based on the data of the association of differentially expressed genes with functional annotations allowed us to illustrate the participation of pJNK and pCREB in the signaling pathways that exhibited changes in their activit…”
BackgroundInfluentialSingle-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction
Chomczynski, P., & Sacchi, N. (1987) · Analytical Biochemistry · doi:10.1016/0003-2697(87)90021-2 · Cited by 46,426 · cited 1×
“The total RNA from the subcortex, was isolated using TRI Reagent (MRC, Cincinnati, OH, USA) and acid guanidinium thiocyanate–phenol– chloroform extraction [51].”
MethodThe MIQE guidelines: minimum information for publication of quantitative real-time PCR experiments
Bustin, S. A., Benes, V., Garson, J. A., Hellemans, J., Huggett, J., Kubista, M., Mueller, R., Nolan, T., Pfaffl, M. W., Shipley, G. L., et al. (2009) · Clinical Chemistry · doi:10.1373/clinchem.2008.112797 · Cited by 16,303 · cited 1×
“Two reference genes, Gapdh and Rpl3, were used to normalize the cDNA samples [52].”
MethodPfaffl, M. W. (2002) · Nucleic Acids Research · doi:10.1093/nar/30.9.e36 · Cited by 7,376 · cited 1×
“Calculations were performed using BestKeeper, version 1 [53] and Relative Expression Software Tool (REST) 2005 software (gene-quantification, Freising-Weihenstephan, Bavaria, Germany) [54].”
MethodPfaffl, M. W., Tichopad, A., Prgomet, C., & Neuvians, T. P. (2004) · Biotechnology Letters · doi:10.1023/b:bile.0000019559.84305.47 · Cited by 5,065 · cited 2×
“The PCR efficiencies were assessed using the amplification of a series of standard dilutions of cDNAs and computed using REST software [54].”
MethodIschemic Cell Death in Brain Neurons
Lipton, P. (1999) · Physiological Reviews · doi:10.1152/physrev.1999.79.4.1431 · Cited by 3,043
A peptide inhibitor of c-Jun N-terminal kinase protects against excitotoxicity and cerebral ischemia
Borsello, T., Clarke, P. G. H., Hirt, L., Vercelli, A., Repici, M., Schorderet, D. F., Bogousslavsky, J., & Bonny, C. (2003) · Nature Medicine · doi:10.1038/nm911 · Cited by 658 · cited 1×
“These data are in good agreement with the results of studies that showed an increase in JNK phosphorylation and in the activity of the JNK signaling pathway in the brains of rodents after ischemia [36].”
ResultTargeting JNK for therapeutic benefit: from junk to gold?
Manning, A. M., & Davis, R. J. (2003) · Nature Reviews Drug Discovery · doi:10.1038/nrd1132 · Cited by 585 · cited 1×
“Phosphorylated JNK (pJNK) alters the activity of many proteins, including the activation of the transcription factors c-JUN, ATF2, and SP-1 [29].”
BackgroundSpreading Depression, Spreading Depolarizations, and the Cerebral Vasculature
Ayata, C., & Lauritzen, M. (2015) · Physiological Reviews · doi:10.1152/physrev.00027.2014 · Cited by 555
Sakamoto, K., Karelina, K., & Obrietan, K. (2011) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2010.07080.x · Cited by 543 · cited 1×
“Unlike MMP-9, pJNK, and c-Fos, the phosphorylated form of the CREB transcription factor (pCREB) regulates the transcriptional programs of synaptic plasticity, neurogenesis, and neuronal survival in the brain [37].”
BackgroundGarcia, J. H., Liu, K.-F., & Ho, K.-L. (1995) · Stroke · doi:10.1161/01.str.26.4.636 · Cited by 361
Dreier, J. P., Fabricius, M., Ayata, C., Sakowitz, O. W., William Shuttleworth, C., Dohmen, C., Graf, R., Vajkoczy, P., Helbok, R., Suzuki, M., et al. (2017) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1177/0271678x16654496 · Cited by 350
One‐Dimensional SDS Gel Electrophoresis of Proteins
Gallagher, S. R. (2012) · Current Protocols in Molecular Biology · doi:10.1002/0471142727.mb1002as97 · Cited by 234
Matrix Metalloproteinase-9 as a Marker for Acute Ischemic Stroke: A Systematic Review
Ramos-Fernandez, M., Bellolio, M. F., & Stead, L. G. (2011) · Journal of Stroke and Cerebrovascular Diseases · doi:10.1016/j.jstrokecerebrovasdis.2009.10.008 · Cited by 220 · cited 1×
“The activation of the MMP-9 protein, which disrupts the stability of the blood–brain barrier, promotes edema and stroke progression [30].”
BackgroundSpreading depolarizations cycle around and enlarge focal ischaemic brain lesions
Nakamura, H., Strong, A. J., Dohmen, C., Sakowitz, O. W., Vollmar, S., Sué, M., Kracht, L., Hashemi, P., Bhatia, R., Yoshimine, T., et al. (2010) · Brain · doi:10.1093/brain/awq117 · Cited by 212
Role of transcription factors in mediating post-ischemic cerebral inflammation and brain damage
YI, J., PARK, S., KAPADIA, R., & VEMUGANTI, R. (2007) · Neurochemistry International · doi:10.1016/j.neuint.2007.04.019 · Cited by 206 · cited 1×
“The transcription factor c-Fos plays a significant role in post-ischemic inflammation [33].”
BackgroundIntact, injured, necrotic and apoptotic cells after focal cerebral ischemia in the rat
Li, Y., Powers, C., Jiang, N., & Chopp, M. (1998) · Journal of the Neurological Sciences · doi:10.1016/s0022-510x(98)00036-7 · Cited by 187
NR4A orphan nuclear receptors as mediators of CREB-dependent neuroprotection
Volakakis, N., Kadkhodaei, B., Joodmardi, E., Wallis, K., Panman, L., Silvaggi, J., Spiegelman, B. M., & Perlmann, T. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1007088107 · Cited by 167 · cited 1×
“CREB also functions as a key hub in the neurotrophin, antiapoptotic, and antioxidant gene network [38].”
BackgroundSpreading Depression and Neurovascular Coupling
Ayata, C. (2013) · Stroke · doi:10.1161/strokeaha.112.680264 · Cited by 165 · cited 1×
“It is known that, together with excitotoxicity, oxidative stress, and inflammation, a significant role is played by the spreading depression (SD) in the pathophysiology of ischemic stroke [43].”
BackgroundA Brief Introduction to the Transduction of Neural Activity into Fos Signal
Chung, L. (2015) · Development & Reproduction · doi:10.12717/dr.2015.19.2.061 · Cited by 164 · cited 2×
“These proteins include matrix metalloproteinase 9 (MMP-9), which is activated during inflammation and may serve as a prognostic indicator of stroke severity [18]; c-Jun N-terminal kinases (JNKs), the activation of which is involved in inflammation and apoptosis [19]; the transcriptional factor c-Fos, which plays a sig…”
BackgroundSerum matrix metalloproteinase-9 levels and prognosis of acute ischemic stroke
Zhong, C., Yang, J., Xu, T., Xu, T., Peng, Y., Wang, A., Wang, J., Peng, H., Li, Q., Ju, Z., et al. (2017) · Neurology · doi:10.1212/wnl.0000000000004257 · Cited by 164 · cited 1×
“These proteins include matrix metalloproteinase 9 (MMP-9), which is activated during inflammation and may serve as a prognostic indicator of stroke severity [18]; c-Jun N-terminal kinases (JNKs), the activation of which is involved in inflammation and apoptosis [19]; the transcriptional factor c-Fos, which plays a sig…”
BackgroundNational Center for Biotechnology Information
National Cancer Institute (2020) · Definitions · doi:10.32388/uq8dyz · Cited by 134
Liang, K., Lee, C., Lin, W., Lin, C., Wu, C., Luo, S., & Yang, C. (2007) · Journal of Cellular Physiology · doi:10.1002/jcp.20992 · Cited by 128 · cited 1×
“It has also been shown that MMP-9 expression could be induced by proinflammatory cytokines through the NF-κB and MAPK signaling pathways [31,32].”
BackgroundChen, S., Zhao, L., Sherchan, P., Ding, Y., Yu, J., Nowrangi, D., Tang, J., Xia, Y., & Zhang, J. H. (2018) · Journal of Neuroinflammation · doi:10.1186/s12974-018-1140-6 · Cited by 122 · cited 1×
“It should be noted that CREB activation and JNK inhibition are involved in the anti-inflammatory and neuroprotective action of melanocortins in models of ischemic and inflammatory processes in the brain [4,60].”
BackgroundWu, X., Fu, S., Liu, Y., Luo, H., Li, F., Wang, Y., Gao, M., Cheng, Y. Z., & Xie, Z. (2019) · Journal of Neuroinflammation · doi:10.1186/s12974-019-1591-4 · Cited by 118 · cited 1×
“These proteins include matrix metalloproteinase 9 (MMP-9), which is activated during inflammation and may serve as a prognostic indicator of stroke severity [18]; c-Jun N-terminal kinases (JNKs), the activation of which is involved in inflammation and apoptosis [19]; the transcriptional factor c-Fos, which plays a sig…”
BackgroundLin, Y., Chen, F., Zhang, J., Wang, T., Wei, X., Wu, J., Feng, Y., Dai, Z., & Wu, Q. (2013) · Journal of Molecular Neuroscience · doi:10.1007/s12031-013-9977-8 · Cited by 82 · cited 1×
“Many drugs, such as cerebrolysin and resveratrol, which have a neuroprotective effect in stroke, also increase the level of active CREB in ischemic brain tissues [40,41].”
BackgroundRepici, M., Centeno, C., Tomasi, S., Forloni, G., Bonny, C., Vercelli, A., & Borsello, T. (2007) · Neuroscience · doi:10.1016/j.neuroscience.2007.08.021 · Cited by 81 · cited 1×
“Research found that stress stimuli cause the rapid and long-term activation of the JNKs involved in ischemic cell death and neuroinflammation, while their inhibition following experimental ischemia causes a pronounced neuroprotective effect [27,28].”
BackgroundZheng, J., Dai, Q., Han, K., Hong, W., Jia, D., Mo, Y., Lv, Y., Tang, H., Fu, H., & Geng, W. (2020) · Journal of Cellular Physiology · doi:10.1002/jcp.29183 · Cited by 74
Dergunova, L. V., Filippenkov, I. B., Stavchansky, V. V., Denisova, A. E., Yuzhakov, V. V., Mozerov, S. A., Gubsky, L. V., & Limborska, S. A. (2018) · BMC Genomics · doi:10.1186/s12864-018-5039-5 · Cited by 70 · cited 6×
“The preparation of materials for studies with a histotopographic notch of the brain and frontal orientation of tissue blocks for their subsequent microtomy in the caudorostral direction was as reported previously [22].”
BackgroundMethodResultInfluentialSelf-citationGuan, X., Wang, Y., Kai, G., Zhao, S., Huang, T., Li, Y., Xu, Y., Zhang, L., & Pang, T. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.01245 · Cited by 70 · cited 1×
“Many drugs, such as cerebrolysin and resveratrol, which have a neuroprotective effect in stroke, also increase the level of active CREB in ischemic brain tissues [40,41].”
BackgroundLIN, C., TSENG, H., HSIEH, H., LEE, C., WU, C., CHENG, C., & YANG, C. (2008) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2008.01.032 · Cited by 65
Intracellular signaling mechanisms of the melanocortin receptors: current state of the art
Rodrigues, A. R., Almeida, H., & Gouveia, A. M. (2015) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-014-1800-3 · Cited by 64 · cited 1×
“Moreover, melanocortin receptors, which mediate the neuroprotective effect of α-MSH, activate CREB [42].”
BackgroundTanaka, K., Nagata, E., Suzuki, S., Dembo, T., Nogawa, S., & Fukuuchi, Y. (1999) · Brain Research · doi:10.1016/s0006-8993(98)01263-3 · Cited by 64 · cited 1×
“A decrease in CREB expression and activation levels was found in the ischemic stroke focus, whereas an increase in these parameters was detected in the peri-infarct area [39].”
BackgroundMelanocortin-1 receptor activation is neuroprotective in mouse models of neuroinflammatory disease
Mykicki, N., Herrmann, A. M., Schwab, N., Deenen, R., Sparwasser, T., Limmer, A., Wachsmuth, L., Klotz, L., Köhrer, K., Faber, C., et al. (2016) · Science Translational Medicine · doi:10.1126/scitranslmed.aaf8732 · Cited by 60 · cited 2×
“These proteins include matrix metalloproteinase 9 (MMP-9), which is activated during inflammation and may serve as a prognostic indicator of stroke severity [18]; c-Jun N-terminal kinases (JNKs), the activation of which is involved in inflammation and apoptosis [19]; the transcriptional factor c-Fos, which plays a sig…”
Background[A nootropic adrenocorticotropin analog 4-10-semax (l5 years experience in its design and study)].
Ашмарин, И. П., Nezavibat'ko, V. N., Myasoedov, N. F., Kamensky, A. A., Grivennikov, I. A., PonomarevaStepnaya, Андреева, Л. А., Kaplan, A., Кошелев, В. Б., & Ryasina, T. V. (1997) · Журнал высшей нервной деятельности им И П Павлова · Cited by 58
Self-citationSpaccapelo, L., Bitto, A., Galantucci, M., Ottani, A., Irrera, N., Minutoli, L., Altavilla, D., Novellino, E., Grieco, P., Zaffe, D., et al. (2011) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2011.09.015 · Cited by 54
Dmitrieva, V. G., Povarova, O. V., Skvortsova, V. I., Limborska, S. A., Myasoedov, N. F., & Dergunova, L. V. (2010) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-009-9432-0 · Cited by 54 · cited 1×
“The study of the molecular mechanisms underlying the actions of Semax using models of cerebral ischemia in rats showed that the peptide acts on the brain transcriptome: it enhances the transcription of neurotrophins and their receptors [13,14], significantly affects the expression of genes associated with the processe…”
BackgroundSelf-citationShan, H.-M., Zang, M., Zhang, Q., Shi, R.-B., Shi, X.-J., Mamtilahun, M., Liu, C., Luo, L.-L., Tian, X., Zhang, Z., et al. (2020) · Journal of Neuroinflammation · doi:10.1186/s12974-020-01838-w · Cited by 53
Spaccapelo, L., Galantucci, M., Neri, L., Contri, M., Pizzala, R., D'Amico, R., Ottani, A., Sandrini, M., Zaffe, D., Giuliani, D., et al. (2013) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2013.03.030 · Cited by 52
Behavioral pharmacology of neuropeptides related to melanocortins and the neurohypophyseal hormones
de Wied, D. (1999) · European Journal of Pharmacology · doi:10.1016/s0014-2999(99)00339-8 · Cited by 51 · cited 1×
“Peptides of the melanocortin family are actively involved in the functioning of the central nervous system because they act as neuroprotective agents [1].”
BackgroundUse of cell-permeable peptides to prevent neuronal degeneration
Borsello, T., & Bonny, C. (2004) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2004.03.008 · Cited by 44 · cited 1×
“These proteins include matrix metalloproteinase 9 (MMP-9), which is activated during inflammation and may serve as a prognostic indicator of stroke severity [18]; c-Jun N-terminal kinases (JNKs), the activation of which is involved in inflammation and apoptosis [19]; the transcriptional factor c-Fos, which plays a sig…”
BackgroundStorozhevykh, T. P., Tukhbatova, G. R., Senilova, Y. E., Pinelis, V. G., Andreeva, L. A., & Myasoyedov, N. F. (2007) · Bulletin of Experimental Biology and Medicine · doi:10.1007/s10517-007-0192-x · Cited by 41 · cited 2×
“Being a synthetic derivative of natural melanocortins, Semax exhibits several of the important neuroprotective properties of α-MSH: it potentiates dopamine and serotoninergic transmission in the striatum [10], exerts neurotrophic effects in primary neuronal cultures [11], and promotes the survival of neurons under con…”
BackgroundResultGiuliani, D., Ottani, A., Neri, L., Zaffe, D., Grieco, P., Jochem, J., Cavallini, G. M., Catania, A., & Guarini, S. (2017) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2016.11.004 · Cited by 38 · cited 1×
“In particular, α-MSH, the amino acid sequence of which coincides completely with the site of amino acids 1–13 of ACTH, exhibits noticeable anti-inflammatory, neurogenic, and neuroprotective effects in models of experimental ischemia [5,7].”
BackgroundTanaka, Y., Nakagomi, N., Doe, N., Nakano-Doi, A., Sawano, T., Takagi, T., Matsuyama, T., Yoshimura, S., & Nakagomi, T. (2020) · Cells · doi:10.3390/cells9061374 · Cited by 37
Melanocortins as potential therapeutic agents in severe hypoxic conditions
Giuliani, D., Minutoli, L., Ottani, A., Spaccapelo, L., Bitto, A., Galantucci, M., Altavilla, D., Squadrito, F., & Guarini, S. (2012) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2012.04.001 · Cited by 35 · cited 1×
“In particular, α-MSH, the amino acid sequence of which coincides completely with the site of amino acids 1–13 of ACTH, exhibits noticeable anti-inflammatory, neurogenic, and neuroprotective effects in models of experimental ischemia [5,7].”
BackgroundStavchansky, V. V., Yuzhakov, V. V., Botsina, A. Y., Skvortsova, V. I., Bondurko, L. N., Tsyganova, M. G., Limborska, S. A., Myasoedov, N. F., & Dergunova, L. V. (2011) · Journal of Molecular Neuroscience · doi:10.1007/s12031-010-9421-2 · Cited by 34 · cited 1×
“The study of the molecular mechanisms underlying the actions of Semax using models of cerebral ischemia in rats showed that the peptide acts on the brain transcriptome: it enhances the transcription of neurotrophins and their receptors [13,14], significantly affects the expression of genes associated with the processe…”
BackgroundSelf-citationRylski, M. (2004) · Frontiers in Bioscience · doi:10.2741/1207 · Cited by 33 · cited 1×
“), c-Fos is involved in the prevention of neuronal death in ischemic conditions [34].”
BackgroundMedvedeva, E. V., Dmitrieva, V. G., Povarova, O. V., Limborska, S. A., Skvortsova, V. I., Myasoedov, N. F., & Dergunova, L. V. (2014) · BMC Genomics · doi:10.1186/1471-2164-15-228 · Cited by 33 · cited 1×
“The study of the molecular mechanisms underlying the actions of Semax using models of cerebral ischemia in rats showed that the peptide acts on the brain transcriptome: it enhances the transcription of neurotrophins and their receptors [13,14], significantly affects the expression of genes associated with the processe…”
BackgroundSelf-citationEremin, K. O., Kudrin, V. S., Saransaari, P., Oja, S. S., Grivennikov, I. A., Myasoedov, N. F., & Rayevsky, K. S. (2005) · Neurochemical Research · doi:10.1007/s11064-005-8826-8 · Cited by 29 · cited 1×
“Being a synthetic derivative of natural melanocortins, Semax exhibits several of the important neuroprotective properties of α-MSH: it potentiates dopamine and serotoninergic transmission in the striatum [10], exerts neurotrophic effects in primary neuronal cultures [11], and promotes the survival of neurons under con…”
BackgroundSelf-citationFilippenkov, I. B., Stavchansky, V. V., Denisova, A. E., Yuzhakov, V. V., Sevan’kaeva, L. E., Sudarkina, O. Y., Dmitrieva, V. G., Gubsky, L. V., Myasoedov, N. F., Limborska, S. A., et al. (2020) · Genes · doi:10.3390/genes11060681 · Cited by 29 · cited 7×
“We have previously shown that, in the subcortical structures of the brain containing the focus of ischemic damage, Semax initiates a large-scale neurotransmitter and anti-inflammatory response that counteracts ischemia–reperfusion [17].”
BackgroundMethodInfluentialSelf-citation[A nootropic adrenocorticotropin analog 4-10-semax (l5 years experience in its design and study)].
Ip, A., Nezavibat'ko, V. N., Nf, M., et al. (1997) · PubMed · Cited by 28
Kaushik, P., Ali, M., Tabassum, H., & Parvez, S. (2020) · Life Sciences · doi:10.1016/j.lfs.2020.118349 · Cited by 26
Williams, A. J., Ling, G., Berti, R., Moffett, J. R., Yao, C., Lu, X. M., Dave, J. R., & Tortella, F. C. (2003) · Experimental Brain Research · doi:10.1007/s00221-003-1566-6 · Cited by 24 · cited 1×
“Concomitantly, starting at 4 h after reperfusion, the expression of the c-Fos protein is not detected in the infarction nucleus [35].”
BackgroundThe efficacy of semax in the tretament of patients at different stages of ischemic stroke
Gusev, E. I., Martynov, M. Y., Kostenko, E. V., Petrova, L. V., & Bobyreva, S. N. (2018) · Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova · doi:10.17116/jnevro20181183261-68 · Cited by 24 · cited 1×
“Without hormonal and toxic side effects, the peptide increases the rate and extent of recovery of neurological functions [8], reduces the severity of neurological deficits, and prolongs the survival of animals with ischemic stroke [9].”
BackgroundMedvedeva, E. V., Dmitrieva, V. G., Limborska, S. A., Myasoedov, N. F., & Dergunova, L. V. (2017) · Molecular Genetics and Genomics · doi:10.1007/s00438-017-1297-1 · Cited by 23 · cited 1×
“The study of the molecular mechanisms underlying the actions of Semax using models of cerebral ischemia in rats showed that the peptide acts on the brain transcriptome: it enhances the transcription of neurotrophins and their receptors [13,14], significantly affects the expression of genes associated with the processe…”
BackgroundSelf-citation(1999) · PubMed · Cited by 21
Mendonça, B. P., Cardoso, J. D. S., Michels, M., Vieira, A. C., Wendhausen, D., Manfredini, A., Singer, M., Dal-Pizzol, F., & Dyson, A. (2020) · Intensive Care Medicine Experimental · doi:10.1186/s40635-020-00300-8 · Cited by 21
(1999) · PubMed · Cited by 18
Developments and new vistas in the field of melanocortins
Leone, S., Noera, G., & Bertolini, A. (2015) · BioMolecular Concepts · doi:10.1515/bmc-2015-0023 · Cited by 13 · cited 5×
“Melanocortins includes the group of melanocyte-stimulating hormones (α-, β-, and γ-MSH) and adrenocorticotropic hormone (ACTH) [6].”
BackgroundInfluentialGusev, E. I., Skvortsova, V. I., & Chukanova, E. I. (2005) · PubMed · Cited by 12
(2013) · PubMed · Cited by 8
Research works printed but not linked: 2
- Paxinos G. Watson C. The Rat Brain in Stereotaxic Coordinates 6th ed. Academic Press San-Diego, CA, USA 2007
- National Center for Biotechnology Information Available online: https://www.ncbi.nlm.nih.gov/Traces/study/?acc=SRP148632 (accessed on 25 May 2021)
Cited by
Translational advances of melanocortin drugs: Integrating biology, chemistry and genetics
Montero‐Melendez, T., Boesen, T. P., & Jonassen, T. E. N. (2022) · Seminars in Immunology · doi:10.1016/j.smim.2022.101603 · Cited by 38
Differential gene expression in the contralateral hemisphere of the rat brain after focal ischemia
Filippenkov, I. B., Remizova, J. A., Denisova, A. E., Stavchansky, V. V., Golovina, K. D., Gubsky, L. V., Limborska, S. A., & Dergunova, L. V. (2023) · Scientific Reports · doi:10.1038/s41598-023-27663-8 · Cited by 20
Self-citationFilippenkov, I. B., Stavchansky, V. V., Denisova, A. E., Valieva, L. V., Remizova, J. A., Mozgovoy, I. V., Zaytceva, E. I., Gubsky, L. V., Limborska, S. A., & Dergunova, L. V. (2021) · Genes · doi:10.3390/genes12121870 · Cited by 18
“Additionally the brain expression profiling of key proteins involved in inflammation and cell death processes (MMP-9, c-Fos, and JNK), as well as neuroprotection and recovery (CREB) was revealed at 24 h after tMCAO [31].”
BackgroundSelf-citationFan, X., Shi, G., Zhao, Y., Yang, J.-J., & Feng, J. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.115520 · Cited by 17
Filippenkov, I. B., Remizova, J. A., Denisova, A. E., Stavchansky, V. V., Golovina, K. D., Gubsky, L. V., Limborska, S. A., & Dergunova, L. V. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23137308 · Cited by 13
“Moreover, previously, we reported the brain expression profile of key proteins involved in inflammation and cell death processes (MMP-9, c-Fos, and JNK), as well as in neuroprotection and recovery (CREB), as detected at 24 h after tMCAO in the IH [13].”
BackgroundSelf-citation
Metadata
- Authors
- Sudarkina, O. Y., Filippenkov, I. B., Stavchansky, V. V., Denisova, A. E., Yuzhakov, V. V., Sevan’kaeva, L. E., Valieva, L. V., Remizova, J. A., Dmitrieva, V. G., Gubsky, L. V., Myasoedov, N. F., Limborska, S. A., & Dergunova, L. V.
- Affiliations
- Kurchatov Institute (RU)
- Pirogov Russian National Research Medical University (RU)
- Ministry of Health of the Russian Federation (RU)
- Corresponding author
- Sudarkina, Olga Yu.
- ORCID
- Venue
- International Journal of Molecular Sciences
- Publisher
- MDPI AG
- Published
- 2021-06-08
- Volume
- 22
- Issue
- 12
- Pages
- 6179
- ISSN
- 1422-0067 (ISSN-L)
- PMC
- PMC8226508
- OpenAlex
- W3166937788
- Cited by
- 15
- References
- 64
- Citations by year
- 2025: 4 · 2024: 2 · 2023: 4 · 2022: 4 · 2021: 1
- FWCI
- 1.10
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- International Journal of Molecular Sciences (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- Russian Science Foundation (19-14-00268)
- Topics
- Life Sciences › Neuroscience › Neurology › Neuroprotection in Cerebral Ischemia
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Health Sciences › Medicine › Clinical Neurology › Acute Ischemic Stroke Management
- Keywords
- Semax, cerebral ischemia-reperfusion injury, ischemic stroke, neuroprotection, transient middle cerebral artery occlusion, brain protein expression, CREB, MMP-9, c-fos, JNK, neuroinflammation, cell death, gene regulatory networks
- MeSH terms
- RNA-Seq, Adrenocorticotropic Hormone, Animals, Brain, Brain Ischemia, Disease Models, Animal, Male, Peptide Fragments, Reperfusion Injury, Rats, Wistar, Neuroprotective Agents, Proteome, Rats, Transcriptome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol and qwen3.8-omni-flash).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.